样式: 排序: IF: - GO 导出 标记为已读
-
A comparative study between cryo-laser cryo-sclerotherapy and sclerotherapy in the treatment of telangiectasia and reticular veins: A randomized controlled trial J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-24 Mahmoud M. Nasser MD, Baker M. Ghoneim MD FRCS FEBVS, Walied Eldaly MD, Hossam Elmahdy MD
Telangiectasias, characterized by dilated venules, are frequently observed in the lower extremities. Sclerotherapy stands out as the predominant treatment of these vascular lesions. The integration of laser therapy with a mild sclerosing agent, serving as an osmotic sclerosant, presents an enhanced cosmetic treatment approach, aiming to optimize outcomes and minimize potential adverse effects. This
-
Venous ablation procedures by provider type, including advanced practice providers J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-20 Clay Wiske MD MBA, Ethan Chervonski BA, Caron B. Rockman MD, Glenn R. Jacobowitz MD, Mikel Sadek MD
The necessary training and certification of providers performing venous ablation has become a topic of debate in recent years. As venous interventions have shifted away from the hospital, the diversity of provider backgrounds has increased. We aimed to characterize superficial venous ablation practice patterns associated with different provider types. We analyzed Medicare Fee-For-Service data from
-
Magnetic resonance lymphangiography: Establishing normal J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-20 Mike Mills MSc, Greta Brezgyte MSc, Bernard Ho MD, Julian Pearce MD, Kristiana Gordon MD, Peter S. Mortimer MD, Pia Ostergaard PhD, Franklyn A. Howe PhD
-
Strategies to reduce rates of severe endothermal heat-induced thrombosis following radiofrequency ablation J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-20 Baqir J. Kedwai BHSc, Joshua T. Geiger MD, Daniel J. Lehane BA, Roan J. Glocker MD MPH, Karina A. Newhall MD MS, Grayson S. Pitcher MD, Jennifer L. Ellis MD, Adam J. Doyle MD
Endothermal heat-induced thrombosis (EHIT) is a potential complication of radiofrequency ablation (RFA). Data on effective prophylaxis of EHIT are limited. In 2018, a high-volume, single institution implemented strategies to decrease the incidence of EHIT, including a single periprocedural prophylactic dose of low-molecular-weight heparin to patients with a great saphenous vein (GSV) diameter of ≥8 mm
-
Initial experience with the ambulatory management of acute iliofemoral deep vein thrombosis with May-Thurner syndrome with percutaneous mechanical thrombectomy, angioplasty and stenting J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-19 Daniel Nguyen BS, Scott S. Berman MD MHA RVT FACS DFSVS, Joshua A. Balderman MD, Joseph E. Sabat MD PhD, Bernardo Mendoza MD, Luis R. Leon MD FACS, John P. Pacanowski MD MBA, Cody Kraemer MD
Patients undergoing intervention for acute iliofemoral deep vein thrombosis (IFDVT) with May-Thurner syndrome (MTS) typically require inpatient (IP) hospitalization for initial treatment with anticoagulation and management with pharmacomechanical thrombectomy. Direct oral anticoagulants and percutaneous mechanical thrombectomy (PMT) devices offer the opportunity for outpatient (OP) management. We describe
-
Obese patients with CEAP (clinical, etiology, anatomy, pathophysiology) C2 and C3 disease show enhanced symptom improvement after endovenous thermal ablation J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-19 Zachary R. Zottola BS, Joshua T. Geiger MD, Geena E. Choo BA, Baqir J. Kedwai BHSc, Mark D. Balceniuk MD MPH, Jennifer L. Ellis MD, Adam J. Doyle MD, Karina A. Newhall MD MS
Endovenous thermal ablation (EVTA) is a prevalent treatment option for patients with severe venous disease. However, the decision to intervene for patients with less severe disease (CEAP [clinical, etiology, anatomy, pathophysiology] C2 and C3) is less clear and becomes further complicated for patients with obesity, a pathology known to increase venous disease symptom severity. Therefore, the objective
-
A giant cystic lymphangioma of the abdominal body wall in a child J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-19 Hua Yi Zhang MD, Dong Zhe Chai MD
-
Reduced calf muscle pump function is not explained by handgrip strength measurements J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-07 Atefeh Ghorbanzadeh MD, Abdi Abud BS, David Liedl RN, Thom Rooke MD, Paul Wennberg MD, Waldemar Wysokinski MD PhD, Robert McBane MD, Damon E. Houghton MD MSc
-
The role and principles of stenting in acute iliofemoral venous thrombosis J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-07 Efthymios D. Avgerinos MD FEBVS, Stephen Black MD, Marie Josee van Rijn MD, Houman Jalaie MD
Catheter-directed interventions for acute iliofemoral deep venous thrombosis (DVT) have been increasingly used over the past 15 years to target severe symptomatology and prevention of post-thrombotic syndrome incidence or reduce its severity if it were to develop. Aside from successful thrombus removal, adjunctive stents are frequently required to treat an uncovered lesion or significant residual thrombus
-
Incidental deep venous thrombosis diagnosed on lower extremity computed tomography is a rare but clinically impactful finding J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-05 Peter A.L. Barros BS, Daniel J. Castro BS, Roger E. Goldman MD PhD, Mimmie Kwong MD MAS
In the setting of a known thrombotic event, computed tomography (CT) studies provide reasonable sensitivity for the diagnosis of deep venous thrombosis (DVT). However, the incidence and accuracy of a DVT diagnosis on CT studies not targeted for the detection of DVT are not well described. In addition, the clinical impact of DVTs incidentally identified on CT is unknown. In this single-institution retrospective
-
Disparities in access to endovenous treatment options in chronic lower extremity superficial venous insufficiency: A national 7-year analysis J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-05 Shin Mei Chan MD, Azadeh Tabari MD, Emma Rudié MS, Brian D'Amore MD, Meredith Cox MD, Ayah Mugahid MD, Shams Iqbal MD, Dania Daye MD PhD
The goal of this study was to analyze trends in treatment access for chronic superficial venous disease and to identify disparities in care. This retrospective study was exempt from institutional review board approval. The American College of Surgeon National Surgical Quality Improvement Program database was used to identify patients who underwent vein stripping (VS) and endovenous procedures for treatment
-
Identification of outcomes in clinical studies for pelvic venous disorders J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-05 Konstantinos Kavallieros BSc, Tasneem Pope MC BChir MA, Matthew Tan MBBS BSc MRCS, Harmeena Kaur BSc, Sergio Gianesini MD PhD FACS, Zaza Lazarashvili MD PhD, Aleksandra Jaworucka-Kaczorowska MD PhD, Sriram Narayanan MBBS MS FRCS, Adam M. Gwozdz MBBS MSc MRCS, Alun H. Davies MA DM DSc FRCS FHEA FEBVS FACPh
There is increasing recognition that health systems need to measure and improve the value of patient care by measuring outcomes. Chronic pelvic pain secondary to pelvic venous insufficiency can have a significant impact on the quality of life (QOL) of women affected. Despite growing recognition, pelvic venous disorders (PeVDs), an important cause of chronic pelvic pain, remain underdiagnosed. Developing
-
Impact of great saphenous vein ablation on healing and recurrence of venous leg ulcers in patients with post-thrombotic syndrome: a retrospective comparative study J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-04 Rashad A. Bishara RPVI MS FRCS, Ahmed Gaweesh MSc MD, Wassila Taha MSc RPVI, Mahmoud M. Tolba MSc, Joseph Shalhoub PhD FRCS FEBVS
The optimal treatment approach for patients with active venous leg ulcers (VLUs) and post-thrombotic syndrome (PTS) associated with great saphenous vein (GSV) reflux remains unclear. To address this gap, we retrospectively compared the outcomes of patients with post-thrombotic VLU with an intact GSV vs those with a stripped or ablated GSV. We retrospectively analyzed data from 48 patients with active
-
Single-session mechanical thrombectomy for iliofemoral deep vein thrombosis using a dual mechanism of action device combining basket and rotational thrombectomy J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-03-04 Stephen A. Black PhD FRCS, Narayanan Thulasidasan MRCS FRCR, Lily Benton BSc, Gerard J. O'Sullivan FRCR FSIR FCIRSE, Mariana Konteva MD, Ivo S. Petrov MD, Stewart R. Walsh MCh, Michael Lichtenberg MD
Interventional treatments for acute iliofemoral deep vein thrombosis (DVT) remain controversial after publication of the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) study. Interventions have been shown to reduce post-thrombotic syndrome severity and improve quality of life in DVT patients, but have been accompanied by risk of major bleeding from
-
Noninvasive measurement of ambulatory venous pressure via column interruption duration in chronic venous disease J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-28 Seshadri Raju MD, David Thaggard BS, Owen Barry MS, Hunter Peeples MS, Arjun Jayaraj MD
Column interruption duration (CID) is a noninvasive surrogate for venous refill time (VFT), a parameter used in ambulatory venous pressure measurement. CID is more accurate than invasive VFT measurement because it avoids errors involved with indirect access of the deep system through the dorsal foot vein. The aim of this retrospective single center study is to analyze the clinical usefulness of CID
-
Characterization and Risk Factors of Inferior Vena Cava Thrombosis in Situ Detected by CT Venography Following Filter placement: A Single-center Retrospective Cohort Study J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-28 Maofeng Gong, Rui Jiang, Zhengli Liu, Boxiang Zhao, Jie Kong, Xu He, Jianping Gu
This study aimed to characterize radiographic characteristics on computed tomography venography (CTV) and risk factors of inferior vena cava thrombosis (IVCT) in situ following retrievable vena cava filter (VCF) placement. Between September 2018 and June 2023, a single-center retrospective cohort study was conducted in patients with or without IVCT in situ following VCF placement. Patient baseline
-
Supermicrosurgery lymphaticovenous and lymphaticolymphatic anastomosis: Technical detail and short-term follow-up for immediate lymphatic reconstruction in breast cancer treatment-related lymphedema prevention J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-28 Bayu Brahma MD, Takumi Yamamoto MD PhD, Sonar Soni Panigoro MD PhD, Samuel Johny Haryono MD PhD, Prasandhya Astagiri Yusuf PhD, Purnomo Sidi Priambodo PhD, Kuntjoro Harimurti MD PhD, Akmal Taher MD PhD
We describe the feasibility and short-term outcome of our surgical technique to repair the lymph vessel disruption directly after axillary lymph node dissection during breast cancer surgery. This procedure is called immediate lymphatic reconstruction to prevent breast cancer treatment-related lymphedema (BCRL), which frequently occurs after axillary lymph node dissection. The surgical technique consisted
-
Risk factors for recanalization of truncal veins following endoluminal ablation J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-28 Matthew Vuoncino MD, Joel Harding DO, Nasim Hedayati MD, Mimmie Kwong MD
Recanalization of target veins after treatment of superficial venous incompetence has clinical implications and may depend on the type of intervention. The aim of this study was to evaluate patient and procedural factors associated with truncal vein recanalization in a large study cohort using the Vascular Quality Initiative (VQI) Varicose Vein Registry. We performed a retrospective review using the
-
Impact of reperfusion therapies on clot resolution and long-term outcomes in patients with pulmonary embolism J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-16 Ka U. Lio MD, Riyaz Bashir MD, Vladimir Lakhter MD, Si Li MD, Joseph Panaro MD, Parth Rali MD
Major progress in reperfusion strategies has substantially improved the short-term outcomes of patients with pulmonary embolism (PE), however, up to 50% of patients report persistent dyspnea after acute PE. A retrospective study of the PE response team registry and included patients with repeat imaging at 3 to 12 months. The primary outcome was to determine the incidence of residual pulmonary vascular
-
-
-
-
Venography as a pragmatic tool for inferior vena cava filter positioning analysis J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-15 Scott Grubman, Cassius Iyad Ochoa Chaar
-
-
Society resources can provide unmet need for real-world data J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-15 Glenn R. Jacobowitz
-
Congestive lower extremity failure: An educational model for improved understanding of phlebolymphedema J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-15 John.A. Chuback, M.Mark Melin, H.Todd Massey, Monika L. Gloviczki
-
-
The state of equipoise in chronic venous origin pelvic pain: Behold the beast J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-15 Nikitha Murali, Ramona Gupta, Kush R. Desai
-
Venous thromboembolism risk models may be ready for a makeover J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-15 Karim M. Salem, Frank T. Padberg
-
The verdict is reached in the JURY study! J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-15 Harold J. Welch
-
Pelvic venous disorders: I found myself within a forest dark J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-15 Sergey G. Gavrilov
-
-
A more appropriate modality may be desired for the measurement of inferior vena cava filter position J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-15 Maofeng Gong, Xu He, Jianping Gu
-
Defining optimal poststent medical therapy in deep venous obstruction remains elusive J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-15 William A. Marston
-
-
A comprehensive ultrasound approach to lower limb varicose veins and abdominal-pelvic connections J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-14 Fanilda Souto Barros MD, Joana Storino MSc, Nathalia Almeida Cardoso da Silva MSc MD, Francine Freitas Fernandes MD, Manuella Barreto Silva MD, Ariadne Bassetti Soares MD
Pelvic venous reflux may be responsible for pelvic venous disorders and/or lower-limb (LL) varicose veins. Ultrasound investigation with Doppler allows a complete study of the entire infra-diaphragmatic venous reservoir. The aim of this study was to guide and standardize the investigation of the pelvic origin of venous reflux in female patients with LL varicose veins. In this case-control study, we
-
Vascular malformations in the thighs of identical twin sisters J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-14 Kai Zheng MD, Qiang-Qiang Nie PhD, Yu-Guang Yang MD, Peng Liu MD, Xue-Qiang Fan MD, Zhi-Dong Ye MD
-
Impact of static foot disorders on the conservative treatment success in chronic venous disease patients without wounds J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-11 Abdulkerim Özhan MD, Fatih Günaydın MD
Chronic venous disease (CVD) and static foot disorders (SFDs) are prevalent conditions that commonly cause lower extremity pain. These conditions share common factors such as age and weight in their etiology. This study aimed to investigate the impact of SFDs on the treatment response of patients undergoing conservative treatment for CVD without wounds. A retrospective evaluation was conducted on 328
-
Treatment of acute pulmonary embolism after catheter-directed thrombolysis with dabigatran vs warfarin: results of a multicenter randomized RE-SPIRE trial J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-10 Alexander A. Gostev PhD MD, Emin Valiev MD, Galina A. Zeidlits MD, Evgeniya A. Shmidt PhD MD, Olesya S. Osipova MD, Alexey V. Cheban MD, Shoraan B. Saaya PhD MD, Olga L. Barbarash PhD MD, Andrey A. Karpenko PhD MD
Thrombolytic therapy is effective method in the high-risk acute pulmonary embolism (PE) treatment. Reduced-dose thrombolysis (RDT) plus oral anticoagulation therapy is effective and safe method in the moderate and severe PE treatment. It is leading to good early and intermediate-term outcomes. In the RE-COVER and RE-COVER II studies, dabigatran showed similar effectiveness as warfarin in the treatment
-
Endovascular filter-protected resection of a large primary great saphenous vein aneurysm containing thrombus J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-03 Hua Yi Zhang, Yao Jin
Abstract not available
-
Review of treatment strategies after lymphadenectomy: from molecular therapeutics to immediate microsurgical lymphatic reconstruction J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-03 Cynthia Sung, Jin Wang, Jeff Chang, Alex K. Wong
Lymphedema is a common complication of cancer treatment such as lymphadenectomy and radiation therapy. It is a debilitating condition with pathologic tissue changes that hinder effective curative treatment and jeopardize patients’ quality of life. Various attempts to prevent the development of lymphedema have been made with improvements in the incidence of the pathology. However, it is still prevalent
-
Review of the literature supporting international clinical practice guidelines on iliac venous stenting and their applicability to Australia and New Zealand practice J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-03 Laurencia Maria Villalba FRACS, Iman Bayat FRACS, Steven Dubenec FRACS, Philip Puckridge FRACS, Shannon Thomas FRACS, Ramon Varcoe PhD FRACS, Thodur Vasudevan FRCS FRACS, Ramesh Tripathi FRCS FRACS DFSVS
The overall goal of this report is to provide a high-level, practical approach to managing venous outflow obstruction (VOO). A group of vascular surgeons from Australia and New Zealand with specific interest, training, and experience in the management of VOO were surveyed to assess current local practices. The results were analyzed and areas of disagreement identified. After this, the group performed
-
Endovenous radiofrequency ablation vs laser ablation in patients with lower extremity varicose veins: A meta-analysis J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-02-03 Wenhong Jiang PhD, Yanying Liang BD, Zhen Long MD, Ming Hu PhD, Han Yang PhD, Xiao Qin MD
Endovenous radiofrequency ablation (RFA) and laser ablation (LA) have been commonly used for treating lower extremity varicose veins (LEVVs). Their therapeutic effects have been widely recognized compared with conventional surgery. However, there have been some controversies regarding the choice between RFA and LA. The objective of our study was to conduct a systematic review and meta-analysis comparing
-
A cadaver study evaluating intraluminal anomalies of the left common iliac vein J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-01-30 Celeste M. Murtha, Richard D. Coats, Grace E. Thiel, Morgan L. McBride, Larry Segars, Anthony B. Olinger
Objective Intraluminal anomalies within the left common iliac vein, characteristic of iliac vein compression syndrome, are thought to result from compression by and pulsation of the overlying right common iliac artery. This cadaver study was designed to expand on the existing literature by surveying and photographing these spurs in addition to exploring whether certain factors, inherent to the cadaver
-
Compensation for external iliac vein hypoplasia via an inherent suprapubic shunt J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-01-28 Ferdinando B.A. Valente, Vincenzo Ardita, Domenico Baccellieri
Abstract not available
-
Racial and Gender Disparities in the Management of Acute Pulmonary Embolism J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-01-29 Shyama Sathianathan, Zachary Meili, Carlos M. Romero, Jordan J. Juarez, Riyaz Bashir
Objective The aim of this study is to assess race and sex disparities in utilization and outcomes of various interventions in acute PE patients. Methods 129,445 patients with acute PE were included from the National Inpatient Sample (NIS) from January 2016 - December 2019. Rates of inferior vena cava (IVC) filter placement, catheter directed thrombolysis (CDT), CDT with ultrasound (CDT-US), systemic
-
Comparison of anticoagulation versus mechanical thrombectomy for the treatment of iliofemoral deep vein thrombosis J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-01-24 Steven Abramowitz, Abdullah Shaikh, Hamid Mojibian, Nicolas J. Mouawad, Matthew C. Bunte, Edvard Skripochnik, Jonathan Lindquist, Fakhir Elmasri, Bhavraj Khalsa, Ambarish Bhat, James Nguyen, Neil Shah, Sonya S. Noor, Douglas Murrey, Sagar Gandhi, Adam Raskin, Jonathan Schor, David J. Dexter
Objective To compare the comparative effects of treatment with contemporary mechanical thrombectomy or anticoagulation on Villalta scores and post thrombotic syndrome incidence through 12 months in iliofemoral deep vein thrombosis. Methods Patients with deep vein thrombosis in the Acute Venous Thrombosis: Thrombus Removal with Adjunctive Catheter-Directed Thrombolysis (ATTRACT) randomized trial and
-
Saphenous vein ablation a word of caution J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-01-19 Alberto Muñoz, Daniel Muñoz, Andrés Cardozo
Abstract not available
-
Diagnosis of Chronic Iliac Venous Obstruction J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-01-18 Arjun Jayaraj, Fabio Rossi, Fedor Lurie, Patrick Muck
Stenting has become the first line of treatment for symptomatic chronic iliofemoral venous obstruction in patients with quality-of-life impairing clinical manifestations who have failed conservative therapy. Patient selection for such intervention is however dependant on clear identification of relevant clinical manifestations and subsequent testing to confirm the diagnosis. In this regard the physician
-
Factors Associated with Ablation Related Thrombus Extension (ARTE) Following Microfoam Versus Radiofrequency Saphenous Vein Closure J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-01-11 Amanda L. Chin, Stephanie D. Talutis, Peter F. Lawrence, Karen Woo, David A. Rigberg, Johnathon C. Rollo, Juan Carlos Jimenez
Objectives Polidocanol endovenous microfoam (MFA) is approved by the US Food and Drug Administration for great saphenous vein (GSV) closure, yet there is little published data on the subsequent risk of ablation related thrombus extension (ARTE). Recent societal practice guidelines recommend against routine post-procedure duplex ultrasound (DU) following thermal ablation of the GSV in asymptomatic patients
-
Left Brachiocephalic Vein-Right Atrial Bypass Procedure for Superior Vena Cava Syndrome in a Long-Term Dialysis Patient J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2024-01-05 Zhengjie Wang, Jie Cai, Yiren Sun, Qi Tong, Tianlei Cui, Yongjun Qian
Abstract not available
-
Value of the STIR sequence of MRI in the staging of Klippel-Trenaunay syndrome complicated with lymphedema J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2023-12-28 Xingpeng Li, Bin Li, Kun Hao, Mengke Liu, Jia Guo, Yimeng Zhang, Qi Hao, Yan Zhang, Xiaoli Sun, Rengui Wang
Objective Currently, the focus on limb lymphedema at home and abroad is on classification and staging. However, few scholars have conducted staging for Klippel-Trenaunay syndrome (KTS)-complicated lymphedema (LE). This study aimed to investigate the value of the STIR sequence of MRI in the staging of Klippel-Trenaunay syndrome complicated with lymphedema (KTS-LE). Methods Forty-six patients who were
-
Traumatic Posterior Tibial Artery Pseudoaneurysm and Arteriovenous Fistula J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2023-12-28 Dong Zhe Chai, Hua Yi Zhang
Abstract not available
-
Cost-effectiveness analysis of intra- and perilesional recombinant human epidermal growth factor versus hydrocolloid therapy in venous ulcer treatment in the Colombian context J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2023-12-23 María Teresa Cacua Sánchez, Ana María Botero, Ornella Moreno- Mattar
Objective To perform a comparative analysis of healthcare expenses and outcomes in response to the question: What is the cost-effectiveness of intra- and perilesional recombinant human epidermal growth factor (rhEGF) compared to hydrocolloid therapy in patients diagnosed with chronic venous insufficiency without infection in Colombia? Method A Markov model was used to determine cost-effectiveness over
-
Editorial Board J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2023-12-22
Abstract not available
-
Correction J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2023-12-22
Abstract not available
-
Can Cross-sectional imaging replace diagnostic venography in Pelvic venous disorder (PeVD)? J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2023-12-20 Mohammed Shahat, Omar M.A. Abdelbaqy, Ahmed M. AbdelHakam, Sahar.H. Ali, Khaled Attalla
Introduction The primary etiology of Pelvic venous disorder (PeVD) is multifactorial and challengeable in vascular surgery as it mandates multidisciplinary team cooperation for its evaluation and management. Methods All patients investigated for (PeVD) in a high-volume, tertiary referral university hospital were identified and analyzed retrospectively during the period (March 2021 and September 2022)
-
A Mapping Review of Pacific Vascular Symposium 6 Initiatives J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2023-12-20 Oscar Moreno, Kiran Kumar, Fedor Lurie, Marc A. Passman, Glen Jacobowitz, Faisal Aziz, Peter Henke, Thomas Wakefield, Andrea Obi
Objectives The 2010 Pacific Vascular Symposium 6 (PVS6) brought venous disease content experts together with a goal of addressing critical issues collated together in the next decade with concrete plans to achieve these goals. This mapping review aims to provide a broader representation of how CVD critical issues progress has been made by extrapolating scientific publications related to the PVS6 initiatives
-
A State-of-the-Art Review of Quality-of-Life Assessment in Venous Disease J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2023-12-19 Jacob Cleman, Kevin Xia, Moosa Haider, Roozbeh Nikooie, Lindsey Scierka, Gaëlle Romain, Robert R. Attaran, Alyssa Grimshaw, Carlos Mena-Hurtado, Kim G. Smolderen
Objective Chronic venous disease is a common condition and has a significant impact on patients’ health status. Validated patient-reported outcome measures (PROMs) used to assess health status are needed to measure health status. This state-of-the-art review summarizes the current validation evidence for disease-specific PROMs for chronic venous disease and provides a framework for their use in the
-
Table of contents J. Vasc. Surg. Venous Lymphatic Disord. (IF 3.2) Pub Date : 2023-12-22
Abstract not available